These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
725 related items for PubMed ID: 25596994
1. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma. Zhao W, Tian B, Wu C, Peng Y, Wang H, Gu WL, Gao FH. Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994 [Abstract] [Full Text] [Related]
3. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers. Yasir S, Herrera L, Gomez-Fernandez C, Reis IM, Umar S, Leveillee R, Kava B, Jorda M. Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859 [Abstract] [Full Text] [Related]
4. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases. Din NU, Fatima S, Ahmad Z. Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630 [Abstract] [Full Text] [Related]
5. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution. Zhou J, Yang X, Zhou L, Zhang P, Wang C. Dis Markers; 2019 Dec; 2019():4708154. PubMed ID: 31737127 [Abstract] [Full Text] [Related]
6. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma. An J, Park CK, Kim M, Joo JW, Cho NH. Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058 [Abstract] [Full Text] [Related]
9. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases]. Zhang W, Yu WJ, Jiang YX, Li YJ, Han F, Liu Y, Han ZL. Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881 [Abstract] [Full Text] [Related]
11. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Wang HY, Mills SE. Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088 [Abstract] [Full Text] [Related]
16. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SK. Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050 [Abstract] [Full Text] [Related]
17. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies. Conner JR, Hirsch MS, Jo VY. Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191 [Abstract] [Full Text] [Related]